These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9213569)

  • 21. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 22. The behavior of the P-value when the alternative hypothesis is true.
    Hung HM; O'Neill RT; Bauer P; Köhne K
    Biometrics; 1997 Mar; 53(1):11-22. PubMed ID: 9147587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On multiperiod crossover studies.
    Fleiss JL
    Biometrics; 1986 Jun; 42(2):449-50. PubMed ID: 3741982
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biostatistics in cancer clinical trials].
    Ohashi Y
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):241-52. PubMed ID: 9480646
    [No Abstract]   [Full Text] [Related]  

  • 25. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design by L. Frison and S.J. Pocock, Statistics in Medicine 1992; 12: 1685-1704.
    Julious SA
    Stat Med; 2000 Nov; 19(22):3133-5. PubMed ID: 11113948
    [No Abstract]   [Full Text] [Related]  

  • 26. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 27. A comment on interim analyses in crossover trials.
    Grieve AP; Senn S
    Biometrics; 1996 Dec; 52(4):1515-20. PubMed ID: 9019232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biometrical methods for the proof of efficacy in regulatory submissions. Non-inferiority in clinical studies].
    Röhmel J; Hauschke D; Koch A; Pigeot I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):562-71. PubMed ID: 15887067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomization and efficiency in Zelen's single-consent design.
    Matts J; McHugh R
    Biometrics; 1987 Dec; 43(4):885-94. PubMed ID: 3427173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of multi-centre trials with binary response.
    Dragalin V; Fedorov V
    Stat Med; 2006 Aug; 25(16):2701-19. PubMed ID: 16252268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and evaluation of multiregional trials with heterogeneous treatment effect across regions.
    Chen CT; Hung HM; Hsiao CF
    J Biopharm Stat; 2012 Sep; 22(5):1037-50. PubMed ID: 22946948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addressing the unit of analysis in medical care studies: a systematic review.
    Calhoun AW; Guyatt GH; Cabana MD; Lu D; Turner DA; Valentine S; Randolph AG
    Med Care; 2008 Jun; 46(6):635-43. PubMed ID: 18520319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On improving research methodology in clinical trials.
    Berger VW; Matthews JR; Grosch EN
    Stat Methods Med Res; 2008 Jun; 17(3):231-42. PubMed ID: 17925317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 36. The analysis of pair-matched case-control studies.
    Le CT
    Biometrics; 1983 Mar; 39(1):294-5. PubMed ID: 6871360
    [No Abstract]   [Full Text] [Related]  

  • 37. Registration of trials and protocols.
    Staessen JA; Bianchi G
    Lancet; 2003 Sep; 362(9389):1009-10. PubMed ID: 14522528
    [No Abstract]   [Full Text] [Related]  

  • 38. An optimal design for screening trials.
    Wang YG; Leung DH
    Biometrics; 1998 Mar; 54(1):243-50. PubMed ID: 9544519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tests for the analysis of variance of crossover designs with correlated errors.
    Bellavance F; Tardif S; Stephens MA
    Biometrics; 1996 Jun; 52(2):607-12. PubMed ID: 8672705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biostatistical methods for demonstrating efficacy in the regulatory setting. An epistemological approach to adaptive designs.
    Koch A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):572-9. PubMed ID: 15887068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.